Is Fecal Calprotectin an Applicable Biomarker of Gut Immune System Activation in Chronic Inflammatory Demyelinating Polyneuropathy? – A Pilot Study

Is Fecal Calprotectin an Applicable Biomarker of Gut Immune System Activation in Chronic Inflammatory Demyelinating Polyneuropathy? – A Pilot Study

Introduction: Chronic inflammatory demyelinating polyneuropathy (CIDP) is a complex autoimmune disease caused by dysregulated response to not fully recognized antigens. Some association between CIDP and inflammatory bowel disease (IBD) has been reported, but the exact pathophysiological links of the...

Full description

Bibliographic Details
Main Authors: Budrewicz, S. (Author), Dziadkowiak, E. (Author), Koszewicz, M. (Author), Mulak, A. (Author)
Format: Article
Language:English
Published: Frontiers Media S.A. 2021
Subjects:
adult
aged
Article
autoimmunity
biological marker
bloating
calgranulin
chronic inflammatory demyelinating polyneuropathy
clinical article
constipation
controlled study
disease course
dysautonomia
enteritis
fecal calprotectin
female
gastrointestinal symptom
gut immune system
gut microbiota
human
immune response
immune system
intestinal inflammation
intestine flora
male
pathogenesis
pilot study
protein expression
stomach emptying
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items